指南与共识产科母胎医学

胎儿生长受限疑似病例管理的循证国家指南:比较、共识与争议

Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy.
指南 / 共识 · Am J Obstet Gynecol · 2018-01-01

本文比较了2010年以来发布的6部关于小于胎龄儿或胎儿生长受限的国家指南,总结了在早孕期风险筛查、低剂量阿司匹林使用、戒烟、宫高测量、脐动脉多普勒、皮质类固醇和硫酸镁使用等方面的共识,并指出了生长监测频率、分娩时机、晚发型胎儿生长受限监测等方面的争议和研究优先方向。

要点

  • 6部指南至少4部同意早孕期风险筛查、对胎盘功能不全主要风险因素孕妇使用低剂量阿司匹林,并强调戒烟。
  • 疑似小于胎龄儿孕妇普遍推荐脐动脉多普勒研究,但诊断后生长扫描频率(2-4周)不一致。
  • 晚发型胎儿生长受限(≥32周)普遍共识使用大脑多普勒影响监测和/或分娩时机。

核心结论

  • 在有高质量随机对照试验和Meta分析证据的领域(如脐动脉多普勒和<34周分娩前使用皮质类固醇),国家小于胎龄儿指南间高度一致。
  • 综述讨论了基于现有随机对照试验在小于胎龄儿指南间可能趋同的领域和争议领域。
  • 研究优先方向包括评估晚孕期扫描预防主要疾病和死亡的有效性,研究晚发型胎儿生长受限且多普勒参数异常胎儿的最佳分娩时机,以及前瞻性研究比较新的国际人群超声标准与当前使用标准。

研究设计与样本

  • 检索MEDLINE、Google和国际指南库,纳入2010年以来发表的6部关于胎儿生长受限/小于胎龄儿管理国家指南的综述。

主要发现

  • 小于胎龄儿占非畸形死产的28-45%,且神经发育迟缓、儿童和成人肥胖及代谢疾病风险更高。
  • 大多数小于胎龄儿在出生前未被识别;改进识别并配合监测和及时分娩与减少小于胎龄儿死产相关。
  • 指南间普遍共识(至少4/6部同意)包括早孕期风险选择和对胎盘功能不全主要风险因素孕妇使用低剂量阿司匹林。
  • 所有指南强调戒烟以预防小于胎龄儿;建议晚孕期测量宫高,其中3部指定使用定制生长曲线图,2部推荐McDonald规则。
  • 不推荐常规晚孕期扫描筛查小于胎龄儿,但主要风险因素孕妇应在晚孕期进行系列扫描。

关键数值与推荐

  • 疑似小于胎龄儿孕妇普遍推荐脐动脉多普勒研究,但诊断后生长扫描频率推荐不一致(2-4周一次)。
  • 晚发型胎儿生长受限(≥32周)普遍共识使用大脑多普勒研究影响监测和/或分娩时机。
  • 胎儿监测方法(多数推荐胎心监护)和推荐分娩时机各不相同。
  • 普遍同意<34周分娩前使用皮质类固醇,一般共识早发型胎儿生长受限(<32周)使用硫酸镁进行神经保护。
  • 多数指南建议<32周胎儿生长受限使用胎心监护监测计划分娩;缺失和反向舒张末期血流胎儿生长受限推荐分娩孕周分别为32至≥34周和30至≥34周。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Small for gestational age is usually defined as an infant with a birthweight <10th centile for a population or customized standard. Fetal growth restriction refers to a fetus that has failed to reach its biological growth potential because of placental dysfunction. Small-for-gestational-age babies make up 28-45% of nonanomalous stillbirths, and have a higher chance of neurodevelopmental delay, childhood and adult obesity, and metabolic disease. The majority of small-for-gestational-age babies are not recognized before birth. Improved identification, accompanied by surveillance and timely delivery, is associated with reduction in small-for-gestational-age stillbirths. Internationally and regionally, detection of small for gestational age and management of fetal growth problems vary considerably. The aim of this review is to: summarize areas of consensus and controversy between recently published national guidelines on small for gestational age or fetal growth restriction; highlight any recent evidence that should be incorporated into existing guidelines; and identify future research priorities in this field. A search of MEDLINE, Google, and the International Guideline Library identified 6 national guidelines on management of pregnancies complicated by fetal growth restriction/small for gestational age published from 2010 onwards. There is general consensus between guidelines (at least 4 of 6 guidelines in agreement) in early pregnancy risk selection, and use of low-dose aspirin for women with major risk factors for placental insufficiency. All highlight the importance of smoking cessation to prevent small for gestational age. While there is consensus in recommending fundal height measurement in the third trimester, 3 specify the use of a customized growth chart, while 2 recommend McDonald rule. Routine third-trimester scanning is not recommended for small-for-gestational-age screening, while women with major risk factors should have serial scanning in the third trimester. Umbilical artery Doppler studies in suspected small-for-gestational-age pregnancies are universally advised, however there is inconsistency in the recommended frequency for growth scans after diagnosis of small for gestational age/fetal growth restriction (2-4 weekly). In late-onset fetal growth restriction (≥32 weeks) general consensus is to use cerebral Doppler studies to influence surveillance and/or delivery timing. Fetal surveillance methods (most recommend cardiotocography) and recommended timing of delivery vary. There is universal agreement on the use of corticosteroids before birth at <34 weeks, and general consensus on the use of magnesium sulfate for neuroprotection in early-onset fetal growth restriction (<32 weeks). Most guidelines advise using cardiotocography surveillance to plan delivery in fetal growth restriction <32 weeks. The recommended gestation at delivery for fetal growth restriction with absent and reversed end-diastolic velocity varies from 32 to ≥34 weeks and 30 to ≥34 weeks, respectively. Overall, where there is high-quality evidence from randomized controlled trials and meta-analyses, eg, use of umbilical artery Doppler and corticosteroids for delivery <34 weeks, there is a high degree of consistency between national small-for-gestational-age guidelines. This review discusses areas where there is potential for convergence between small-for-gestational-age guidelines based on existing randomized controlled trials of management of small-for-gestational-age pregnancies, and areas of controversy. Research priorities include assessing the utility of late third-trimester scanning to prevent major morbidity and mortality and to investigate the optimum timing of delivery in fetuses with late-onset fetal growth restriction and abnormal Doppler parameters. Prospective studies are needed to compare new international population ultrasound standards with those in current use.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. McCowan LM, Figueras F, Anderson NH, et al. Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy. Am J Obstet Gynecol. 2018. PMID: 29422214. doi:10.1016/j.ajog.2017.12.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。